| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenotype | 41 | 2025 | 4598 | 1.680 |
Why?
|
| Exome | 19 | 2025 | 1087 | 1.540 |
Why?
|
| Pedigree | 29 | 2024 | 1728 | 1.320 |
Why?
|
| Genetic Variation | 11 | 2025 | 1631 | 1.300 |
Why?
|
| Neurodevelopmental Disorders | 9 | 2023 | 545 | 1.300 |
Why?
|
| Genetic Predisposition to Disease | 18 | 2025 | 3506 | 1.270 |
Why?
|
| Mutation | 28 | 2024 | 6336 | 1.270 |
Why?
|
| Genetic Association Studies | 21 | 2022 | 868 | 1.230 |
Why?
|
| Genetic Diseases, Inborn | 9 | 2021 | 464 | 1.130 |
Why?
|
| DNA Copy Number Variations | 15 | 2024 | 1034 | 1.080 |
Why?
|
| Mutation, Missense | 14 | 2024 | 947 | 1.010 |
Why?
|
| Genome, Human | 8 | 2024 | 1351 | 0.970 |
Why?
|
| Siblings | 2 | 2024 | 200 | 0.930 |
Why?
|
| Craniofacial Abnormalities | 3 | 2022 | 253 | 0.850 |
Why?
|
| Microcephaly | 7 | 2023 | 354 | 0.840 |
Why?
|
| Intellectual Disability | 10 | 2022 | 1091 | 0.810 |
Why?
|
| Genomics | 12 | 2025 | 1681 | 0.770 |
Why?
|
| Alleles | 13 | 2024 | 1724 | 0.730 |
Why?
|
| Nonsense Mediated mRNA Decay | 4 | 2025 | 39 | 0.720 |
Why?
|
| Immunologic Deficiency Syndromes | 6 | 2021 | 221 | 0.690 |
Why?
|
| Nerve Tissue Proteins | 3 | 2024 | 1167 | 0.690 |
Why?
|
| Nervous System Diseases | 4 | 2019 | 412 | 0.680 |
Why?
|
| Nuclear Proteins | 8 | 2024 | 1351 | 0.660 |
Why?
|
| Heart Defects, Congenital | 5 | 2025 | 1884 | 0.650 |
Why?
|
| Codon, Nonsense | 5 | 2025 | 145 | 0.650 |
Why?
|
| Vesicular Transport Proteins | 2 | 2020 | 123 | 0.640 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2020 | 73 | 0.630 |
Why?
|
| Databases, Genetic | 7 | 2022 | 507 | 0.620 |
Why?
|
| Homozygote | 8 | 2024 | 570 | 0.610 |
Why?
|
| Developmental Disabilities | 7 | 2024 | 742 | 0.610 |
Why?
|
| Membrane Proteins | 9 | 2025 | 1622 | 0.590 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 182 | 0.590 |
Why?
|
| Urogenital Abnormalities | 4 | 2023 | 164 | 0.570 |
Why?
|
| 46, XX Disorders of Sex Development | 3 | 2023 | 26 | 0.570 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 116 | 0.550 |
Why?
|
| Sequence Analysis, DNA | 5 | 2021 | 1837 | 0.540 |
Why?
|
| Consanguinity | 2 | 2021 | 120 | 0.540 |
Why?
|
| Fibroblasts | 3 | 2023 | 928 | 0.530 |
Why?
|
| Humans | 97 | 2025 | 134152 | 0.520 |
Why?
|
| Arabs | 1 | 2016 | 30 | 0.510 |
Why?
|
| Autophagy | 1 | 2020 | 429 | 0.510 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2019 | 179 | 0.500 |
Why?
|
| Proteins | 3 | 2018 | 1101 | 0.500 |
Why?
|
| T-Box Domain Proteins | 5 | 2022 | 127 | 0.490 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2025 | 2947 | 0.460 |
Why?
|
| Dwarfism | 3 | 2022 | 105 | 0.460 |
Why?
|
| Genetics, Medical | 1 | 2015 | 123 | 0.440 |
Why?
|
| Genomic Instability | 3 | 2022 | 248 | 0.420 |
Why?
|
| Male | 52 | 2025 | 66125 | 0.410 |
Why?
|
| Charcot-Marie-Tooth Disease | 3 | 2023 | 240 | 0.410 |
Why?
|
| Female | 55 | 2025 | 71926 | 0.410 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 697 | 0.390 |
Why?
|
| Syndrome | 9 | 2022 | 1167 | 0.380 |
Why?
|
| Child, Preschool | 26 | 2024 | 14884 | 0.370 |
Why?
|
| Heterotaxy Syndrome | 2 | 2024 | 64 | 0.350 |
Why?
|
| Cytoskeletal Proteins | 2 | 2024 | 284 | 0.350 |
Why?
|
| Child | 29 | 2024 | 25889 | 0.330 |
Why?
|
| Congenital Abnormalities | 3 | 2023 | 298 | 0.330 |
Why?
|
| Megalencephaly | 2 | 2022 | 60 | 0.330 |
Why?
|
| Actins | 3 | 2023 | 353 | 0.330 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2021 | 225 | 0.310 |
Why?
|
| Limb Deformities, Congenital | 2 | 2022 | 112 | 0.310 |
Why?
|
| Genetic Markers | 3 | 2019 | 635 | 0.300 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2018 | 964 | 0.290 |
Why?
|
| Infant | 19 | 2024 | 13240 | 0.290 |
Why?
|
| Pathology, Molecular | 2 | 2018 | 67 | 0.290 |
Why?
|
| RNA Helicases | 2 | 2019 | 74 | 0.290 |
Why?
|
| Cerebellar Ataxia | 2 | 2019 | 69 | 0.280 |
Why?
|
| Anodontia | 2 | 2018 | 33 | 0.280 |
Why?
|
| Exons | 4 | 2018 | 839 | 0.280 |
Why?
|
| Cohort Studies | 9 | 2021 | 5222 | 0.280 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 143 | 0.280 |
Why?
|
| Arthrogryposis | 2 | 2019 | 40 | 0.280 |
Why?
|
| Heterozygote | 6 | 2019 | 728 | 0.280 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 551 | 0.280 |
Why?
|
| Atrophy | 2 | 2020 | 254 | 0.270 |
Why?
|
| Autistic Disorder | 2 | 2022 | 374 | 0.270 |
Why?
|
| Mullerian Ducts | 3 | 2023 | 46 | 0.270 |
Why?
|
| Transcription Factors | 8 | 2022 | 2738 | 0.260 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2019 | 149 | 0.260 |
Why?
|
| Genotype | 6 | 2024 | 2814 | 0.260 |
Why?
|
| Adolescent | 20 | 2024 | 20624 | 0.250 |
Why?
|
| Abnormalities, Multiple | 3 | 2022 | 979 | 0.250 |
Why?
|
| Young Adult | 14 | 2024 | 9944 | 0.250 |
Why?
|
| Infant, Newborn | 13 | 2024 | 8623 | 0.250 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2022 | 596 | 0.250 |
Why?
|
| Chromosome Aberrations | 2 | 2019 | 628 | 0.230 |
Why?
|
| Carrier Proteins | 2 | 2021 | 1077 | 0.230 |
Why?
|
| Chromosome Inversion | 1 | 2025 | 77 | 0.230 |
Why?
|
| Rare Diseases | 2 | 2024 | 209 | 0.230 |
Why?
|
| Killer Cells, Natural | 2 | 2018 | 357 | 0.230 |
Why?
|
| von Willebrand Diseases | 1 | 2025 | 55 | 0.230 |
Why?
|
| Essential Hypertension | 1 | 2024 | 12 | 0.220 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 416 | 0.220 |
Why?
|
| Homeodomain Proteins | 4 | 2021 | 589 | 0.220 |
Why?
|
| Repressor Proteins | 3 | 2018 | 873 | 0.220 |
Why?
|
| Biological Variation, Population | 1 | 2024 | 27 | 0.220 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 51 | 0.210 |
Why?
|
| von Willebrand Factor | 1 | 2025 | 205 | 0.210 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 400 | 0.210 |
Why?
|
| Wnt Proteins | 3 | 2021 | 226 | 0.210 |
Why?
|
| Adult | 19 | 2025 | 31943 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 188 | 0.200 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2023 | 45 | 0.200 |
Why?
|
| GPI-Linked Proteins | 2 | 2021 | 108 | 0.200 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 136 | 0.200 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.200 |
Why?
|
| Epilepsy | 2 | 2021 | 896 | 0.200 |
Why?
|
| Muscle Spasticity | 2 | 2020 | 61 | 0.190 |
Why?
|
| Polydactyly | 1 | 2022 | 18 | 0.190 |
Why?
|
| Apyrase | 1 | 2022 | 21 | 0.190 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2022 | 12 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2023 | 150 | 0.190 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 30 | 0.190 |
Why?
|
| Muscle Hypotonia | 3 | 2022 | 200 | 0.190 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2022 | 41 | 0.190 |
Why?
|
| Osteoporosis | 1 | 2023 | 141 | 0.190 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 74 | 0.190 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2022 | 36 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 260 | 0.190 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2021 | 28 | 0.180 |
Why?
|
| Software | 2 | 2024 | 735 | 0.180 |
Why?
|
| Family | 4 | 2019 | 593 | 0.180 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2022 | 101 | 0.180 |
Why?
|
| Adenosine Triphosphatases | 3 | 2017 | 217 | 0.180 |
Why?
|
| Cerebellum | 3 | 2022 | 467 | 0.180 |
Why?
|
| Eye Abnormalities | 1 | 2022 | 103 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 3 | 2021 | 675 | 0.180 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 8 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2025 | 514 | 0.180 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 320 | 0.180 |
Why?
|
| Peptides | 1 | 2025 | 863 | 0.180 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2021 | 5 | 0.180 |
Why?
|
| Wolffian Ducts | 1 | 2021 | 11 | 0.180 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 168 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 2 | 2021 | 256 | 0.180 |
Why?
|
| Lymphopenia | 1 | 2021 | 40 | 0.170 |
Why?
|
| Agammaglobulinemia | 1 | 2021 | 44 | 0.170 |
Why?
|
| Genetic Testing | 4 | 2024 | 1099 | 0.170 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 20 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 31 | 0.170 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 31 | 0.170 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 64 | 0.170 |
Why?
|
| Progeria | 1 | 2019 | 17 | 0.160 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 86 | 0.160 |
Why?
|
| Netrins | 1 | 2019 | 5 | 0.160 |
Why?
|
| Quadriplegia | 1 | 2020 | 34 | 0.160 |
Why?
|
| Lissencephaly | 1 | 2019 | 11 | 0.160 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 32 | 0.160 |
Why?
|
| Cleft Lip | 1 | 2021 | 134 | 0.160 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2019 | 33 | 0.160 |
Why?
|
| Fibrillin-1 | 1 | 2019 | 62 | 0.160 |
Why?
|
| Information Dissemination | 1 | 2022 | 199 | 0.160 |
Why?
|
| Cleft Palate | 1 | 2021 | 155 | 0.160 |
Why?
|
| Lipodystrophy | 1 | 2019 | 34 | 0.160 |
Why?
|
| White Matter | 1 | 2022 | 211 | 0.160 |
Why?
|
| RNA Splice Sites | 1 | 2020 | 99 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 169 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 628 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 255 | 0.160 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 159 | 0.160 |
Why?
|
| DNA-Binding Proteins | 4 | 2022 | 2178 | 0.160 |
Why?
|
| Deafness | 1 | 2020 | 87 | 0.160 |
Why?
|
| Ankyrins | 1 | 2020 | 96 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2022 | 214 | 0.150 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2019 | 21 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 45 | 0.150 |
Why?
|
| F-Box Proteins | 1 | 2019 | 38 | 0.150 |
Why?
|
| Immunologic Memory | 1 | 2020 | 200 | 0.150 |
Why?
|
| Neoplasm Proteins | 2 | 2023 | 719 | 0.150 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2019 | 46 | 0.150 |
Why?
|
| Myelin P2 Protein | 1 | 2018 | 10 | 0.150 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 267 | 0.150 |
Why?
|
| Behavior | 1 | 2019 | 76 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2019 | 103 | 0.150 |
Why?
|
| Animals | 16 | 2024 | 36557 | 0.150 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 408 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 337 | 0.150 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2023 | 422 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 21 | 0.150 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 130 | 0.150 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 709 | 0.140 |
Why?
|
| Mitochondrial Proteins | 2 | 2017 | 253 | 0.140 |
Why?
|
| Chloride Channels | 1 | 2018 | 63 | 0.140 |
Why?
|
| Alu Elements | 1 | 2018 | 67 | 0.140 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 159 | 0.140 |
Why?
|
| Brain | 3 | 2021 | 3224 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 158 | 0.140 |
Why?
|
| beta Catenin | 1 | 2019 | 232 | 0.140 |
Why?
|
| Marfan Syndrome | 1 | 2019 | 150 | 0.140 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 130 | 0.140 |
Why?
|
| Fibromatosis, Gingival | 1 | 2017 | 5 | 0.140 |
Why?
|
| Mice | 11 | 2024 | 19055 | 0.140 |
Why?
|
| Cell Line | 5 | 2023 | 2864 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 36 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2018 | 72 | 0.140 |
Why?
|
| Retinitis Pigmentosa | 1 | 2018 | 96 | 0.140 |
Why?
|
| Heart Atria | 1 | 2020 | 338 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 174 | 0.140 |
Why?
|
| Arginine | 1 | 2019 | 351 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 138 | 0.130 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 157 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2019 | 311 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 316 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2019 | 628 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 43 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 622 | 0.130 |
Why?
|
| Calcium Channels | 1 | 2017 | 166 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 182 | 0.130 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 482 | 0.130 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 271 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 207 | 0.130 |
Why?
|
| Data Mining | 1 | 2016 | 59 | 0.120 |
Why?
|
| Tenascin | 1 | 2016 | 33 | 0.120 |
Why?
|
| Mediator Complex | 1 | 2016 | 57 | 0.120 |
Why?
|
| Face | 1 | 2017 | 190 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 353 | 0.120 |
Why?
|
| Computational Biology | 2 | 2021 | 890 | 0.120 |
Why?
|
| Sirolimus | 1 | 2018 | 253 | 0.120 |
Why?
|
| Micrognathism | 1 | 2016 | 68 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 83 | 0.120 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2016 | 106 | 0.120 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2024 | 580 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2018 | 230 | 0.120 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 97 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 293 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2019 | 404 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 78 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 235 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 625 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2025 | 2915 | 0.110 |
Why?
|
| Codon, Terminator | 2 | 2025 | 27 | 0.110 |
Why?
|
| Scoliosis | 1 | 2016 | 143 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 286 | 0.110 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 319 | 0.110 |
Why?
|
| Cytokines | 1 | 2020 | 1401 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 69 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2016 | 290 | 0.110 |
Why?
|
| Epigenomics | 1 | 2015 | 196 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 218 | 0.110 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 137 | 0.100 |
Why?
|
| Turkey | 3 | 2018 | 67 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2015 | 378 | 0.100 |
Why?
|
| DNA Mutational Analysis | 3 | 2019 | 843 | 0.100 |
Why?
|
| Lung | 2 | 2019 | 1577 | 0.090 |
Why?
|
| Genome-Wide Association Study | 4 | 2025 | 1880 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2019 | 825 | 0.090 |
Why?
|
| Mammals | 2 | 2023 | 282 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 2669 | 0.090 |
Why?
|
| Mitochondria | 1 | 2016 | 757 | 0.090 |
Why?
|
| Paternal Inheritance | 2 | 2021 | 11 | 0.080 |
Why?
|
| DNA Helicases | 2 | 2023 | 254 | 0.080 |
Why?
|
| Frameshift Mutation | 2 | 2023 | 201 | 0.080 |
Why?
|
| Transcriptome | 1 | 2016 | 1138 | 0.080 |
Why?
|
| Facies | 2 | 2021 | 156 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2024 | 17540 | 0.080 |
Why?
|
| Base Sequence | 3 | 2018 | 3180 | 0.080 |
Why?
|
| Loss of Function Mutation | 2 | 2021 | 162 | 0.070 |
Why?
|
| Protein Domains | 2 | 2019 | 260 | 0.070 |
Why?
|
| Chromosome Segregation | 2 | 2017 | 69 | 0.070 |
Why?
|
| X Chromosome Inactivation | 2 | 2018 | 66 | 0.070 |
Why?
|
| Genetic Linkage | 2 | 2019 | 482 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2018 | 344 | 0.070 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2017 | 81 | 0.070 |
Why?
|
| Retina | 2 | 2022 | 503 | 0.070 |
Why?
|
| Axons | 2 | 2022 | 397 | 0.060 |
Why?
|
| Embryonic Development | 2 | 2019 | 224 | 0.060 |
Why?
|
| DNA Replication | 2 | 2019 | 366 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2019 | 4934 | 0.060 |
Why?
|
| Zebrafish | 2 | 2019 | 421 | 0.060 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2025 | 4 | 0.060 |
Why?
|
| ABO Blood-Group System | 1 | 2025 | 69 | 0.060 |
Why?
|
| Ethanolamine | 1 | 2024 | 8 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2018 | 4016 | 0.060 |
Why?
|
| Gestational Age | 2 | 2019 | 1229 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 548 | 0.060 |
Why?
|
| Choline | 1 | 2024 | 56 | 0.060 |
Why?
|
| Neoplasms | 1 | 2019 | 3038 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2024 | 48 | 0.050 |
Why?
|
| Chile | 1 | 2024 | 27 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2024 | 111 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 14 | 0.050 |
Why?
|
| Cell Movement | 2 | 2019 | 920 | 0.050 |
Why?
|
| Glycosylation | 1 | 2023 | 129 | 0.050 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2023 | 99 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 2795 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 93 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 231 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 16 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 96 | 0.050 |
Why?
|
| Age of Onset | 1 | 2024 | 638 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 26 | 0.050 |
Why?
|
| Egypt | 1 | 2021 | 30 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 151 | 0.050 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 28 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 89 | 0.050 |
Why?
|
| Middle Aged | 5 | 2025 | 29397 | 0.050 |
Why?
|
| Calpain | 1 | 2021 | 43 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 143 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2022 | 196 | 0.050 |
Why?
|
| PAX8 Transcription Factor | 1 | 2021 | 16 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 845 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2021 | 27 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2021 | 24 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2021 | 39 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 268 | 0.040 |
Why?
|
| Atrioventricular Block | 1 | 2021 | 41 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 3798 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 204 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 8 | 0.040 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 2020 | 32 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 112 | 0.040 |
Why?
|
| Ataxia | 1 | 2022 | 177 | 0.040 |
Why?
|
| Uniparental Disomy | 1 | 2021 | 51 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 187 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3188 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2021 | 124 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 182 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 741 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2019 | 53 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 393 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 252 | 0.040 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2019 | 12 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 112 | 0.040 |
Why?
|
| Tubulin | 1 | 2019 | 77 | 0.040 |
Why?
|
| Connectin | 1 | 2019 | 29 | 0.040 |
Why?
|
| Neutropenia | 1 | 2021 | 205 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 468 | 0.040 |
Why?
|
| Maternal Inheritance | 1 | 2019 | 15 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 64 | 0.040 |
Why?
|
| Peroxidases | 1 | 2019 | 29 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 133 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 37 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 241 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2019 | 175 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 587 | 0.040 |
Why?
|
| Democratic Republic of the Congo | 1 | 2018 | 16 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 425 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2018 | 2045 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 140 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 131 | 0.040 |
Why?
|
| Pakistan | 1 | 2018 | 95 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2018 | 89 | 0.040 |
Why?
|
| Organogenesis | 1 | 2019 | 84 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2019 | 255 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 71 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2018 | 111 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 65 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 599 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2019 | 132 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 88 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 120 | 0.040 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2018 | 79 | 0.040 |
Why?
|
| Neurons | 2 | 2019 | 2050 | 0.040 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2017 | 13 | 0.040 |
Why?
|
| Immunological Synapses | 1 | 2018 | 30 | 0.030 |
Why?
|
| Workflow | 1 | 2018 | 135 | 0.030 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 128 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3668 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2021 | 291 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2018 | 116 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 252 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 82 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 779 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 131 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2018 | 304 | 0.030 |
Why?
|
| Mosaicism | 1 | 2019 | 248 | 0.030 |
Why?
|
| Laminin | 1 | 2017 | 72 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 137 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 33 | 0.030 |
Why?
|
| Viremia | 1 | 2018 | 136 | 0.030 |
Why?
|
| Gametogenesis | 1 | 2017 | 25 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2017 | 253 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 507 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2017 | 83 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 243 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2018 | 234 | 0.030 |
Why?
|
| CD56 Antigen | 1 | 2016 | 29 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 380 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 276 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 278 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 31 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3857 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 103 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1682 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 112 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 34 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 79 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 1384 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 367 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2018 | 372 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 344 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2017 | 149 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1713 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 64 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 2016 | 48 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 120 | 0.030 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 22 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 539 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 362 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 279 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 1148 | 0.030 |
Why?
|
| United States | 2 | 2024 | 11763 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 299 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 325 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 811 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 153 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 150 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2017 | 285 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 724 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1765 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1132 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3743 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 378 | 0.030 |
Why?
|
| Hypogonadism | 1 | 2019 | 320 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1859 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 222 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1040 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 82 | 0.030 |
Why?
|
| Amino Acids | 1 | 2017 | 688 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 79 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 467 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 475 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 567 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2017 | 376 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 390 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 178 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 607 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1332 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 548 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2563 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1493 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2016 | 840 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 1148 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1979 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 519 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1736 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3980 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 11181 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1051 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1595 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4808 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 5086 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2198 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3114 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 21773 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4879 | 0.020 |
Why?
|